NICE recommends tucatinib for advanced breast cancer
NICE has recommended use of tucatinib as an option to treat HER2-positive breast cancer that has spread in people who have already tried 2...
Novo Nordisk launches two smart connected insulin pens in the UK
Global healthcare company, Novo Nordisk has announced availability of two smart connected insulin pens, NovoPen® 6 and NovoPen Echo® Plus on prescription for diabetic people...
RPS to host sessions to help shape response for NHS primary care review
The Royal Pharmaceutical Society (RPS) will be hosting two sessions for members to help them shape response to an NHS review of primary care...
England scraps mandatory Covid shots for health staff
Health and social care workers in England, including those working in community pharmacy, will no longer have to have a Covid shot or jab...
Novavax expects to apply for full approval of Covid vaccine later this year
American biotechnology company Novavax said on Monday (February 28) it would pursue full approval of its Covid-19 vaccine in the second half of this...
New pharmacy with automation and innovative services opens in Letchworth
A newly redesigned pharmacy with robotic automation and innovative new services has opened in Letchworth, Hertfordshire last week.
The pharmacy, which is owned by award-winning...
Essential Pharma hikes drug prices by up to 400 per cent
Essential Pharma, a private equity-owned pharmaceutical company has increased prices of three antidepressants and two drugs used to treat heart conditions by up to...
NHS chief announces new campaign for early detection of cancer
NHS chief executive Amanda Pritchard today (March 1) announced a new campaign to promote early detection of cancer, when it is easier to treat.
The...
PSNC reminds pharmacy contractors to make PQS declaration by Wednesday
The Pharmaceutical Services Negotiating Committee (PSNC) has reminded community pharmacy contractors to make their Pharmacy Quality Scheme (PQS) 2021/22 declaration by 11.59pm on Wednesday...
AstraZeneca inks deal with Swiss firm Neurimmune for antibody drug
AstraZeneca Plc has agreed to develop an antibody-based therapy with Swiss biotechnology firm Neurimmune for a rare, underdiagnosed condition that can lead to heart failure...
Current Issue March 2024
